Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failure

Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failure

US Patent 9198951 · Granted Dec 1, 2015

Estimated economic value: $14,049,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or pro2022
Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or pro2022
Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or pro2022
Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or pro2022
Methods of reducing extravasation of inflammatory cells2021
Methods for detecting cardiac damage2021
Method for achieving desired glial growth factor 2 plasma levels2020
Compositions and methods for treatment during non-acute periods following CNS ne2020
Compositions and methods for treatment during non-acute periods following CNS ne2020
Compositions and methods of using chondroitinase ABCI mutants2019
Compositions and methods of using chondroitinase ABCI mutants2019
Methods for detecting cardiac damage2019